Policyholder Services

I would like to implant a micro-invasive glaucoma surgery (MIGS) device during cataract surgery. Will my policy cover me for this?

Yes. The iStent Trabecular Micro-Bypass Stent is a micro-invasive glaucoma surgery (MIGS) device approved by the FDA for use in conjunction with cataract surgery to reduce intraocular pressure in adult patients with mild to moderate open-angle glaucoma currently treated with ocular hypotensive medication. Insertion of this device (or other MIGS devices, once they obtain FDA approval) is covered under OMIC’s standard Surgery Class 3 coverage.

Patients undergoing insertion of a MIGS device should be carefully monitored postoperatively for proper maintenance of intraocular pressure as additional treatment or medication may be necessary.

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment

Six reasons OMIC is the best choice for ophthalmologists in America.

#5. Expertise unmatched.

OMIC's sole mission is to serve ophthalmology. The premier source of ophthalmic claims data and loss prevention materials, OMIC's member hotline is the most used ophthalmic consultative service of its kind and OMIC.com is the most visited web site in America for ophthalmic risk management advice and patient consent documents.